With RA the conformity index increases about 20% compared to DCA. Verifications mean gamma passing rates have been 99.6 (2%/2mm) and 97.9 (1%/1mm). Conclusions: A feasible process has been described to treat SRS benign lesions with RapidArc. An adequate level of efficiency and accuracy is achieved.
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Monte Carlo calculation for Intra-Operative Radiotherapy (IOERT) with electron beams T. De Brouwer 1 , C. Vandekerkhove 1 , S. Simon 2 1 Institut Jules Bordet, Radiotherapy, Brussels, Belgium 2 Institut Jules Bordet (ULB), Radiotherapy, Brussels, Belgium Purpose/Objective: The Intra-Operative Radiation Therapy (IORT) is a specialized irradiation technique which allows a single high radiation dose (10 -25 Gy) delivery during the surgical intervention, after the visible tumor resection. The choice of protecting shield materials is a compromise between the surgeon's requirement to have it as thin as possible, as well as the necessity to totally absorb the primary radiation. The main aim of this work is to perform Monte Carlo simulation for IOERT beams with different shielding plates in place, and compare it with measurement to check dose in front of and behind the shielding plate. There are a few papers related to IORT but none of them focuses on shielding plate design.
Materials and Methods: I.A. Monte Carlo Simulation
The Mobetron 1000 head was modeled using the EGSnrc/BEAMnrc simulation package. The dose distribution in water for flat applicators was simulated with the DOSXYZnrc code, which scores dose in a water Phantom. This study is done for the most clinically used applicator (5.5 cm) with the maximum energy used of the accelerator (12MeV). Seven Mobetron components are modeled: electron source, first scattering foil, second scattering foil, fixed collimator #1 , ion monitor chamber, fixed collimator #2 and the patient applicator. It is necessary to validate Monte Carlo model against measurements (PDD, Profile ). A method to find the correct electron beam characteristics impinging on the scattering foil is to change iteratively some parameters and compare the simulations with measurements. We had to optimize the energy spectrum and the FWHM of the Gaussian source.
I.B.Types of Shields studied
There are many shield types used in different Mobetron centers. They are all composed of two materials: either PMMA/Cu, or Al/Pb or Al/Steel. All of them have been simulated with Monte Carlo and some of them have been measured with Radiochromic films. The shield was usually placed at the 90% isodose depth in water. Results: On figure 1, the matching between measured and calculated PDD and profiles is presented. On figure 2 there is an example of dose map distribution with an Al/Pb shield placed at 3.7cm depth. It is clear that there is no transmission and there is a significant backscattering effect close to the shield. Other types of shields gave similar results for transmission but slightly different results for backscattering.
Interestingly, we can use the backscattering effect to enhance the dose homogeneity in the target volume and a theoretical shield design will be presented. 
Conclusions:
-All of the studied shielding plates are clinically acceptable. Normally, the surgeon would prefer the thinnest shield (Al/Pb).
-The good alignment of the applicator and the shield is a key issue The purpose of this study is to quantify and compare different dose/volume constraints for the organs at risk (OARs) in breast cancer treatment based in the DVH of each study, in order to establish the most useful parameters to evaluate this type of treatment in our institution. Materials and Methods: 544 women were evaluated. Studies were grouped regarding the type of treatment (breast/chest wall, breast + boost, breast + regional nodal irradiation (RNI), breast+boost+RNI) and the fractionation scheme (2Gy or 2.66Gy per fraction). Different dose/volume constraints for the heart and lung have been evaluated for each patient (Table 1) . Also, for each patient the clinical pathology before and after the treatment has been evaluated.
EP-1566 Analysis of the different dose-volume constraints in 3D-
Results: From 544 patients only 2 developed symptomatic pulmonary complications and 4 patients developed cardiac complications probably related with the radiotherapy treatment. Regarding the dose/volume constraints: •For both lungs, V20Gy(16Gy*) <25% is achieved in about 97% of the patients. •For the ipsilateral lung, Dmean<17 Gy is achieved in more than 95% of the patients, except in treatments which includes the RNI, where only 64% meet the criteria. Furthermore, the criteria V30Gy<200cc is only achieved by 33% of the patients, in the best situation (breast/chest wall hypofractionated) meanwhile for treatments which includes RNI only 9% meet the objective. For V20Gy<25% the results are in same direction as V30Gy<200cc. •For the heart, V30Gy(24Gy*)<30 cc is achieved by 29% of the patients in the best situation. V20Gy<10%, V40Gy<5% and V25Gy<10% is achieved by 45%, 41.4% and 52% in the best situations, meanwhile V45Gy<50% and V60Gy<30% is achieved by 100%. (*) value for hypofractionated treatments Conclusions: The type of treatment have a big influence in the percentage of cases that meet the dose/volume constraints. Treatments which include the RNI have a low percentage of achievements. According to our data, we can conclude that the V30(24)Gy<30cc for the heart and the V30(24)Gy<200cc for the ipsilateral lung are quite ambitious constraints and presents a strong dependency of the appearance of the RNI. Also, parameters as the V45Gy<33% , for the ipsilateral lung and V45Gy<50% for the heart, are very relaxed and the achievement of these constraints doesn't mean that the plan would be an optimal plan.
